Annual Cash & Cash Equivalents
$605.38 M
+$362.88 M+149.65%
31 December 2023
Summary:
Exact Sciences annual cash & cash equivalents is currently $605.38 million, with the most recent change of +$362.88 million (+149.65%) on 31 December 2023. During the last 3 years, it has fallen by -$885.91 million (-59.41%). EXAS annual cash & cash equivalents is now -59.41% below its all-time high of $1.49 billion, reached on 31 December 2020.EXAS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$588.83 M
+$58.65 M+11.06%
30 September 2024
Summary:
Exact Sciences quarterly cash and cash equivalents is currently $588.83 million, with the most recent change of +$58.65 million (+11.06%) on 30 September 2024. Over the past year, it has dropped by -$5.78 million (-0.97%). EXAS quarterly cash and cash equivalents is now -60.52% below its all-time high of $1.49 billion, reached on 31 December 2020.EXAS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EXAS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +149.7% | -1.0% |
| 3 y3 years | -59.4% | +115.1% |
| 5 y5 years | +277.4% | -43.1% |
EXAS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.4% | +149.7% | -2.7% | +210.3% |
| 5 y | 5 years | -59.4% | +277.4% | -60.5% | +232.2% |
| alltime | all time | -59.4% | >+9999.0% | -60.5% | >+9999.0% |
Exact Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $588.83 M(+11.1%) |
| June 2024 | - | $530.18 M(+52.6%) |
| Mar 2024 | - | $347.49 M(-42.6%) |
| Dec 2023 | $605.38 M(+149.6%) | $605.38 M(+1.8%) |
| Sept 2023 | - | $594.61 M(-1.6%) |
| June 2023 | - | $604.36 M(+43.4%) |
| Mar 2023 | - | $421.37 M(+73.8%) |
| Dec 2022 | $242.49 M(-23.1%) | $242.49 M(+3.1%) |
| Sept 2022 | - | $235.31 M(+10.3%) |
| June 2022 | - | $213.42 M(+12.5%) |
| Mar 2022 | - | $189.78 M(-39.8%) |
| Dec 2021 | $315.47 M(-78.8%) | $315.47 M(+15.2%) |
| Sept 2021 | - | $273.78 M(-24.7%) |
| June 2021 | - | $363.71 M(-67.0%) |
| Mar 2021 | - | $1.10 B(-26.0%) |
| Dec 2020 | $1.49 B(+741.3%) | $1.49 B(+84.9%) |
| Sept 2020 | - | $806.68 M(+14.6%) |
| June 2020 | - | $703.93 M(+0.4%) |
| Mar 2020 | - | $701.05 M(+295.5%) |
| Dec 2019 | $177.25 M(+10.5%) | $177.25 M(-82.9%) |
| Sept 2019 | - | $1.03 B(+404.4%) |
| June 2019 | - | $205.06 M(-28.1%) |
| Mar 2019 | - | $285.20 M(+77.8%) |
| Dec 2018 | $160.43 M(+107.0%) | $160.43 M(-0.8%) |
| Sept 2018 | - | $161.71 M(-28.3%) |
| June 2018 | - | $225.66 M(+51.8%) |
| Mar 2018 | - | $148.69 M(+91.9%) |
| Dec 2017 | $77.49 M(+58.4%) | $77.49 M(+52.4%) |
| Sept 2017 | - | $50.84 M(-71.8%) |
| June 2017 | - | $180.41 M(+360.2%) |
| Mar 2017 | - | $39.21 M(-19.9%) |
| Dec 2016 | $48.92 M(+18.9%) | $48.92 M(-22.9%) |
| Sept 2016 | - | $63.45 M(+29.5%) |
| June 2016 | - | $49.01 M(-6.0%) |
| Mar 2016 | - | $52.15 M(+26.8%) |
| Dec 2015 | $41.13 M(-29.2%) | $41.13 M(+30.5%) |
| Sept 2015 | - | $31.52 M(-6.6%) |
| June 2015 | - | $33.77 M(-17.0%) |
| Mar 2015 | - | $40.68 M(-30.0%) |
| Dec 2014 | $58.13 M(+352.3%) | $58.13 M(+108.9%) |
| Sept 2014 | - | $27.83 M(+34.4%) |
| June 2014 | - | $20.71 M(+16.3%) |
| Mar 2014 | - | $17.81 M(+38.6%) |
| Dec 2013 | $12.85 M(-3.7%) | $12.85 M(+32.3%) |
| Sept 2013 | - | $9.71 M(-54.9%) |
| June 2013 | - | $21.52 M(+167.2%) |
| Mar 2013 | - | $8.05 M(-39.7%) |
| Dec 2012 | $13.35 M | $13.35 M(+5.4%) |
| Sept 2012 | - | $12.66 M(+110.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | - | $6.03 M(-51.0%) |
| Mar 2012 | - | $12.29 M(-65.6%) |
| Dec 2011 | $35.78 M(-54.6%) | $35.78 M(+616.3%) |
| Sept 2011 | - | $5.00 M(-86.9%) |
| June 2011 | - | $38.26 M(-46.9%) |
| Mar 2011 | - | $72.07 M(-8.5%) |
| Dec 2010 | $78.75 M(+259.2%) | $78.75 M(+278.3%) |
| Sept 2010 | - | $20.82 M(-14.1%) |
| June 2010 | - | $24.23 M(+33.4%) |
| Mar 2010 | - | $18.17 M(-17.1%) |
| Dec 2009 | $21.92 M(+344.1%) | $21.92 M(-3.8%) |
| Sept 2009 | - | $22.78 M(+85.4%) |
| June 2009 | - | $12.29 M(+241.8%) |
| Mar 2009 | - | $3.60 M(-27.2%) |
| Dec 2008 | $4.94 M(+10.1%) | $4.94 M(-18.7%) |
| Sept 2008 | - | $6.07 M(+10.3%) |
| June 2008 | - | $5.50 M(+37.6%) |
| Mar 2008 | - | $4.00 M(-10.9%) |
| Dec 2007 | $4.49 M(-7.1%) | $4.49 M(-37.4%) |
| Sept 2007 | - | $7.16 M(+86.8%) |
| June 2007 | - | $3.83 M(-0.4%) |
| Mar 2007 | - | $3.85 M(-20.3%) |
| Dec 2006 | $4.83 M(-62.9%) | $4.83 M(-39.5%) |
| Sept 2006 | - | $7.99 M(-42.2%) |
| June 2006 | - | $13.83 M(+33.1%) |
| Mar 2006 | - | $10.39 M(-20.1%) |
| Dec 2005 | $13.01 M(-0.6%) | $13.01 M(-24.0%) |
| Sept 2005 | - | $17.12 M(-2.8%) |
| June 2005 | - | $17.63 M(+88.8%) |
| Mar 2005 | - | $9.33 M(-28.7%) |
| Dec 2004 | $13.09 M(-7.8%) | $13.09 M(-20.9%) |
| Sept 2004 | - | $16.55 M(+19.6%) |
| June 2004 | - | $13.85 M(-42.7%) |
| Mar 2004 | - | $24.18 M(+70.3%) |
| Dec 2003 | $14.20 M(-18.6%) | $14.20 M(-11.8%) |
| Sept 2003 | - | $16.11 M(+9.3%) |
| June 2003 | - | $14.74 M(+25.1%) |
| Mar 2003 | - | $11.78 M(-32.4%) |
| Dec 2002 | $17.44 M(-69.3%) | $17.44 M(-28.6%) |
| Sept 2002 | - | $24.42 M(-57.9%) |
| June 2002 | - | $57.96 M(+15.5%) |
| Mar 2002 | - | $50.20 M(-11.7%) |
| Dec 2001 | $56.84 M(+114.7%) | $56.84 M(-9.2%) |
| Sept 2001 | - | $62.64 M(-6.8%) |
| June 2001 | - | $67.23 M(-6.5%) |
| Mar 2001 | - | $71.94 M |
| Dec 2000 | $26.47 M(+644.9%) | - |
| Dec 1999 | $3.55 M(-59.7%) | - |
| Dec 1998 | $8.83 M | - |
FAQ
- What is Exact Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Exact Sciences?
- What is Exact Sciences annual cash & cash equivalents year-on-year change?
- What is Exact Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Exact Sciences?
- What is Exact Sciences quarterly cash and cash equivalents year-on-year change?
What is Exact Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of EXAS is $605.38 M
What is the all time high annual cash & cash equivalents for Exact Sciences?
Exact Sciences all-time high annual cash & cash equivalents is $1.49 B
What is Exact Sciences annual cash & cash equivalents year-on-year change?
Over the past year, EXAS annual cash & cash equivalents has changed by +$362.88 M (+149.65%)
What is Exact Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EXAS is $588.83 M
What is the all time high quarterly cash and cash equivalents for Exact Sciences?
Exact Sciences all-time high quarterly cash and cash equivalents is $1.49 B
What is Exact Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, EXAS quarterly cash and cash equivalents has changed by -$5.78 M (-0.97%)